CEO SUMMARY: When formed in 1995, Laboratory Corporation of America faced a financially-hostile marketplace for lab testing services. However, strategic planning retreats in 1997 and 1999 were pivotal in redirecting this billion-dollar lab behemoth toward financial stability. During 2000, its share price soared as LabCorp posted strong gains in revenue and profit. Here’s a look […]
- "Newmaker Interview"
Market Changes Lead LabCorp To Follow New Strategic Direction
LabCorp is building expertise in genomic and esoteric testing to differentiate itself in the market
- By Robert Michel
- > From the Volume VIII No. 4 - March 19, 2001 Issue
- Tags: Anatomic pathology, anatomic pathology services, cap, clinical testing, clinical trials, dark report, days sales outstanding, diagnostic lab, diagnostic lab test, Diagnostic technology, Diagnostic tests, dso, ehi, Esoteric testing, genetic test, genetic testing, genomics, hie, impac, lab industry, lab test, lab test pricing, lab testing, lab testing services, lab tests, laboratories, laboratory company, laboratory test, laboratory testing, laboratory tests, management systems, pathologists, pathology service, pathology services, the dark report, the laboratory
